Stories

This week's research roundup features: Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation

For Billy Dowell Jr., a competitive golfer, focus, determination, and course correction are essential to excelling at the sport. These skills, along with routine follow-up care and testing, are also important to navigating a life impacted by multiple chronic autoimmune conditions.

As a hospital account executive for Mayo Clinic Laboratories, Vanessa Gonzalez Casar supports and partners with local hospitals to ensure their patients receive the right test at the right time.

As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.

This week's research roundup features: Neuropathological findings in COVID-19: an autopsy cohort

Terra Lasho is an assistant professor of medicine and principal research technologist for the Division of Hematology, where she works to help transform patient care from bench to bedside.

This week's research roundup features: Expanding the platelet inventory to mitigate the impact of severe shortages

Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.

This week's research roundup features: In vitro activity of a hypochlorous acid-generating electrochemical bandage against yeast biofilms

As a clinical specialty representative for Mayo Clinic Laboratories, Doug Smith works to promote Mayo Clinic’s core values and support community-based health care and integrated delivery systems through the sale of Mayo Clinic Laboratories tests.

This week's research roundup features: Clinical impact of KIR haplotypes in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic hematopoietic stem cell transplantation

Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the confirmatory diagnosis they needed.

This week's research roundup features: AMPK: The key to ischemia-reperfusion injury